BackgroundCheck.run
Search For

Jianping P Huang13108 Thomas Morris Trce, Carmel, IN 46033

Jianping Huang Phones & Addresses

13108 Thomas Morris Trce, Carmel, IN 46033   

5404 Zoeller Cir, Carmel, IN 46033    317-8430109   

Boulder, CO   

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Mentions for Jianping P Huang

Jianping Huang resumes & CV records

Resumes

Jianping Huang Photo 13

Jianping Huang

Jianping Huang Photo 14

Jianping Huang

Publications & IP owners

Us Patents

Agents And Methods For The Treatment Of Proliferative Diseases

US Patent:
6743785, Jun 1, 2004
Filed:
May 21, 2002
Appl. No.:
10/130801
Inventors:
Rima Salim Al-Awar - Raleigh NC
Kyle Andrew Hecker - Indianapolis IN
Jianping Huang - Carmel IN
Sajan Joseph - Indianapolis IN
James Edward Ray - Indianapolis IN
Philip Parker Waid - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D40314
US Classification:
514183, 540471, 540561, 540555, 514220, 514219, 514411, 514375, 514366, 514257, 544249, 548427, 548219, 548217, 548150
Abstract:
The present invention provides selective kinase inhibitors of formula (I).

Agents And Methods For The Treatment Of Proliferative Diseases

US Patent:
6867198, Mar 15, 2005
Filed:
Dec 18, 2000
Appl. No.:
10/130493
Inventors:
Rima Salim Al-Awar - Raleigh NC, US
Kyle Andrew Hecker - Indianapolis IN, US
James Edward Ray - Indianapolis IN, US
Jianping Huang - Carmel IN, US
Sajan Joseph - Indianapolis IN, US
Tiechao Li - Fishers IN, US
Michael Paal - Hamburg, DE
Radhakrishnan Rathnachalam - Carmel IN, US
Chuan Shih - Carmel IN, US
Philip Parker Waid - Indianapolis IN, US
Xun Zhou - Carmel IN, US
Guoxin Zhu - Noblesville IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K031/435
A61K031/445
US Classification:
514 44, 514214, 514392, 536 286, 536 2431, 435 691, 530350, 548455, 548430, 546 94, 540479
Abstract:
The present invention provides selective kinase inhibitors of formula (I).

7-Phenyl-Isoquinoline-5-Sulfonylamino Derivatives As Inhibitors Of Akt (Protein Kinase B)

US Patent:
7449477, Nov 11, 2008
Filed:
Nov 22, 2004
Appl. No.:
10/595798
Inventors:
David Anthony Barda - Indianapolis IN, US
Jianping Huang - Carmel IN, US
Sajan Joseph - Indianapolis IN, US
Ho-Shen Lin - Indianapolis IN, US
Michael Enrico Richett - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D 217/22
C07D 401/12
A61K 31/4725
A61K 31/472
US Classification:
514307, 514218, 5142278, 5142328, 51425305, 540575, 544 60, 544128, 544363, 546139, 546148
Abstract:
The present invention relates to compounds Formula (I) as inhibitors of AKT activity, which are useful for the treatment of susceptible neoplasms and viral infections.

Method For Solution Phase Synthesis Of Oligonucleotides

US Patent:
2004011, Jun 17, 2004
Filed:
Jul 17, 2001
Appl. No.:
09/907125
Inventors:
Wolfgang Pieken - Boulder CO, US
Danny McGee - Redwood City CA, US
Alecia Settle - Superior CO, US
Yansheng Zhai - Palo Alto CA, US
Jianping Huang - Carmel IN, US
Assignee:
Proligo LLC
International Classification:
C07H021/04
US Classification:
536/025300, 536/025340
Abstract:
This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture of oligonucleotides with high efficiency.

P70 S6 Kinase Inhibitors

US Patent:
2009016, Jun 25, 2009
Filed:
Mar 2, 2009
Appl. No.:
12/396103
Inventors:
Robert Dean Dally - Carmel IN, US
Jianping Huang - Carmel IN, US
Sajan Joseph - Bangalore, IN
Timothy Alan Shepherd - Indianapolis IN, US
Christian L. Holst - Schenectday NY, US
International Classification:
C07D 487/04
US Classification:
544256
Abstract:
The present invention provides p70 S6 kinase inhibitors of the formula:pharmaceutical formulations comprising them, and methods for their use.

P70 S6 Kinase Inhibitors

US Patent:
2012007, Mar 22, 2012
Filed:
Nov 30, 2011
Appl. No.:
13/307560
Inventors:
Robert Dean Dally - Carmel IN, US
Jianping Huang - Carmel IN, US
Sajan Joseph - Carmel IN, US
Timothy Alan Shepherd - Indianapolis IN, US
Christian L. Holst - Schenectday NY, US
Assignee:
ELI LILLY AND COMPANY - Indianapolis IN
International Classification:
A61K 31/519
A61P 35/00
A61K 31/52
C07D 487/04
C07D 473/32
US Classification:
51425216, 544262, 5142621, 544280, 5142651, 544277, 51426322
Abstract:
The present invention provides p70 S6 kinase inhibitors of the formula:pharmaceutical formulations comprising them, and methods for their use.

Method For Solution Phase Synthesis Of Oligonucleotides

US Patent:
6262251, Jul 17, 2001
Filed:
Apr 6, 1998
Appl. No.:
9/051449
Inventors:
Wolfgang Pieken - Boulder CO
Danny McGee - San Mateo CA
Alecia Settle - Superior CO
Yansheng Zhai - Palo Alto CA
Jianping Huang - Lafayette CO
Assignee:
Proligo LLC - Boulder CO
International Classification:
C07H 102
C07C22902
C07K 102
US Classification:
536 253
Abstract:
This invention discloses an improved method for the sequential solution phase synthesis of oligonucleotides. The method lends itself to automation and is ideally suited for large scale manufacture of oligonucleotides with high efficiency.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.